Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Jedd Wolchok
Person

Jedd Wolchok

Tracked across 1 events · 102 articles · First seen Aug 19, 2026 · Last active Aug 20, 2026

Sentiment
55
Attention
8
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
8 55
Tech
Moderna Merck mRNA melanoma vaccine trial success
Moderna and Merck & Co. announced on August 19, 2026, that their personalized mRNA cancer vaccine, Intismeran, combined with Merck's immunotherapy drug Pembrolizumab, met its primary and secondary goals in a Phase 3 trial for…
Impact: As a melanoma expert, Wolchok commented on the significance of the trial for cancer immunotherapy, adding expert validation.
Aug 19, 2026 · 102 articles
ERGEN INTELLIGENCE
Track Jedd Wolchok live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.